Sudeep Pharma Limited (BOM:544619)

Market Cap	75.49B
Revenue (ttm)	6.17B +34.4%
Net Income	1.68B +26.3%
EPS	15.40 +25.4%
Shares Out	n/a
PE Ratio	44.88
Forward PE	40.05
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,081
Average Volume	11,697
Open	664.70
Previous Close	671.70
Day's Range	654.00 - 674.70
52-Week Range	524.95 - 795.80
Beta	n/a
RSI	63.29
Earnings Date	Feb 6, 2026

About Sudeep Pharma

Sudeep Pharma Limited manufactures and sells excipients and specialty ingredients for the pharmaceutical, food, and nutrition industries in United States, Europe, United Kingdom, and Latin America. The company provides mineral salts, such as calcium, zinc, iron, potassium, magnesium, sodium, and copper to a range of health-focused applications; and calcium carbonate, which is used as an active pharmaceutical ingredient for various therapeutic applications. It also offers micronutrient premixes, encapsulated ingredients, liposomal and spray-drie...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1989
• Employees: 740
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544619

Financial Performance

In fiscal year 2025, Sudeep Pharma's revenue was 5.02 billion, an increase of 9.30% compared to the previous year's 4.59 billion. Earnings were 1.39 billion, an increase of 4.14%.